ALPHA IVF GROUP BERHAD

KLSE: 0303 (ALPHA)

Last update: 07 May, 3:17AM

0.325

0.00 (0.00%)

Market Trend

Short Term Medium Term
Industry Medical Care Facilities (MY) Mixed Mixed
Medical Care Facilities (Global) Bullish Bearish
Stock ALPHA - -

Similar Stocks

Stock Market Cap DY P/E P/B
ALPHA 2 B - - -
TMCLIFE 1 B 1.15% 23.83 1.41
DCHCARE 309 M - 31.00 4.80
IHH 56 B 2.95% 18.56 1.89
KPJ 9 B 1.88% 33.17 3.61
OPTIMAX 359 M 1.82% 33.00 5.52

Alpha IVF Group Bhd is a fertility care specialist. Its focusing on the provision of assisted reproductive services in Malaysia and Singapore, Assisted reproductive services is a general term that includes all types of fertility treatment and procedures to assist people that have difficulties getting pregnant. It offer a range of assisted reproductive services such as IVF, to assist the patient with infertility conditions to achieve clinical pregnancy and also provide other assisted reproductive procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostics, testing and screening procedures as well as cryopreservation of eggs, sperm and embryos.

Sector Healthcare
Industry Medical Care Facilities
Investment Style Small Growth
52 Weeks Range
0.300 - 0.345
High 0.420 (AmInvest, 29.23%) Buy
Median 0.420 (29.23%)
Average 0.420 (29.23%)
Total 1 Buy
Firm Date Target Price Call Price @ Call
AmInvest 25 Apr 2024 0.420 (29.23%) Buy 0.330
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
DATO DR LEE SOON SOO 0.323 - 2,086,800 668,377
MADAM SIA BEE KENG - 0.320 -250,000 -80,000
Aggregate Net Quantity 1,836,800
Aggregate Net Value ($) 588,377
Aggregate Avg. Buy ($) 0.323
Aggregate Avg. Sell ($) 0.320
Name Holder Date Type Quantity Price Value ($)
DATO' DR LEE SOON SOO Director 16 May 2024 Acquired (+) 60,100 0.325 19,533
DATO DR LEE SOON SOO Substantial Shareholder 16 May 2024 Acquired (+) 60,100 0.325 19,533
DATO' DR LEE SOON SOO Director 15 May 2024 Acquired (+) 983,300 0.320 314,656
DATO DR LEE SOON SOO Substantial Shareholder 15 May 2024 Acquired (+) 983,300 0.320 314,656
MADAM SIA BEE KENG Director 15 May 2024 Disposed (-) 250,000 0.320 80,000
Date Type Details
09 May 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DATO' DR TAN KEE KWONG
09 May 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
07 May 2024 TheEdge Bursa Malaysia's 2023 IPOs largely deliver gains without major exits
03 May 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - MADAM SIA BEE KENG
03 May 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
17 Apr 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATO DR LEE SOON SOO
17 Apr 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DATO' DR LEE SOON SOO
17 Apr 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
16 Apr 2024 TheEdge Alpha IVF makes RM13.6 mil net profit in 3Q, sees rising demand for fertility solutions amid resurgence in medical tourism
16 Apr 2024 TheEdge MyEG, HeiTech Padu, Apex Healthcare, Globetronics Technology, Kossan Rubber, Tomei, GDEX, Serba Dinamik, Alpha IVF and Comfort Gloves
16 Apr 2024 Announcement Quarterly rpt on consolidated results for the financial period ended 29/02/2024
12 Apr 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
12 Apr 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DATO' DR LEE SOON SOO
12 Apr 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATO DR LEE SOON SOO
08 Apr 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DATO' DR LEE SOON SOO
08 Apr 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATO DR LEE SOON SOO
08 Apr 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
04 Apr 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DATO' DR LEE SOON SOO
04 Apr 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATO DR LEE SOON SOO
04 Apr 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
01 Apr 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATO DR LEE SOON SOO
01 Apr 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DATO' DR LEE SOON SOO
01 Apr 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
29 Mar 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Intention to Deal During Closed Period
27 Mar 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Intention to Deal During Closed Period
27 Mar 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Intention to Deal During Closed Period
26 Mar 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Intention to Deal During Closed Period
22 Mar 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DATO DR TAN KEE KWONG
22 Mar 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - ACE SPECIALISTS SDN BHD
22 Mar 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
22 Mar 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
22 Mar 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR NG PENG WAH
22 Mar 2024 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
22 Mar 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATO DR LEE SOON SOO
22 Mar 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MADAM LEE SOON AI
22 Mar 2024 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LEONG WAI YEW
22 Mar 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - MADAM SIA BEE KENG
22 Mar 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DATUK LEE SAY TSHIN
22 Mar 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - MR TUNG FOOK HENG
22 Mar 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR NG PENG WAH
22 Mar 2024 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DATO' DR LEE SOON SOO
20 Mar 2024 Announcement Initial Public Offering
18 Mar 2024 Announcement Quarterly rpt on consolidated results for the financial period ended 30/11/2023
18 Mar 2024 Announcement ALPHA IVF GROUP BERHAD ("ALPHA IVF" OR "COMPANY") INITIAL PUBLIC OFFERING IN CONJUNCTION WITH THE LISTING OF ALPHA IVF ON THE ACE MARKET OF BURSA MALAYSIA SECURITIES BERHAD
01 Mar 2024 Announcement Timetable for IPO
01 Mar 2024 Announcement INITIAL PUBLIC OFFERING ("IPO") OF 1,458,000,000 ORDINARY SHARES IN ALPHA IVF GROUP BERHAD ("ALPHA IVF" OR "COMPANY") ("IPO SHARES") IN CONJUNCTION WITH THE LISTING OF AND QUOTATION FOR ITS ENTIRE ISSUED ORDINARY SHARES ON THE ACE MARKET OF BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES") COMPRISING A PUBLIC ISSUE OF 364,500,000 NEW SHARES ("ISSUE SHARES") AND OFFER FOR SALE OF 1,093,500,000 EXISTING SHARES ("OFFER SHARES") INVOLVING: (I) AN INSTITUTIONAL OFFERING OF 1,239,300,000 IPO SH
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No data